logo
episode-header-image
Dec 2024
20m 5s

Primary resistance to BCMA-targeted bisp...

AMERICAN SOCIETY OF HEMATOLOGY
About this episode
tail spinning
Up next
Nov 2025
New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials
In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA ... Show More
18m 36s
Nov 2025
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ... Show More
9m 36s
Oct 2025
Review Series on Follicular Lymphoma
In this Review Series episode, Associate Editor Dr. Philippe Armand speaks with multiple authors about what it might look like to improve treatments follicular lymphoma, a disease that has been put on the backburner of innovation due to its generally treatable nature. Dr. Armand ... Show More
17m 38s
Recommended Episodes
May 2023
Multiple Myeloma
<p>This week’s episode is part 2 of our plasma cell dyscrasias series. We will go over the important details on risk stratification, as well as initial and relapse treatment options for Multiple Myeloma, with key details on the pharmacology of myeloma drugs.</p><p><br/></p> 
16m 47s
Jan 2023
Episode 044: Myeloma Series, Pt.5 - Myeloma Treatment
<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.</p><p class="" style="white-space:pre-wrap;">Co ... Show More
34m 19s
Jan 2023
Episode 042: Myeloma Series, Pt.3 - Intro to Multiple Myeloma
<p class="" style="white-space:pre-wrap;">In this continuation of our myeloma series, we discuss the progression of MGUS &amp; smoldering myeloma to multiple myeloma. We also outline how to risk stratify a patient with multiple myeloma and gauge their response to treatment.&nbsp; ... Show More
35m 54s
Sep 2025
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
<p class="" data-rte-preserve-empty="true" style="white-space:pre-wrap;"><strong>This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ... Show More
36m 11s
Sep 2025
S2 Episode 3: When Is the Best Time to Use CAR T-Cell Therapy in Multiple Myeloma?
Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002715. ... Show More
24m 38s
Feb 2023
Episode 047: Myeloma Series, Pt.8- Myeloma Maintenance Therapy
tail spinning
30m 11s
May 2022
S1 Episode 2: Frontline Therapy for Multiple Myeloma
Joseph Mikhael, MD, and Peter Voorhees, MD, discuss frontline therapy for multiple myeloma and new options for both transplant-eligible and transplant-ineligible patients. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/view ... Show More
23m 37s
Sep 2023
Episode 075: Intro to CAR-T, Bispecifics (BiTE), and Autologous Transplant
<p class="" style="white-space:pre-wrap;">In this week’s episode, we pause from our discussion about DLBCL to talk about the fundamentals of CAR-T, BiTE and autologous transplants, which will lay the foundation for subsequent discussions about DLBCL. These therapies are the talk ... Show More
26m 55s
Aug 2022
Jason Westin, MD, MS, FACP - Rising to the Occasion: Improving Outcomes in Leukemia, Lymphoma, and Multiple Myeloma With CAR T-Cell Therapy in Community Practice
Go online to PeerView.com/NMF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Chimeric antigen receptor T-cell (CAR T) therapy, a validated novel therapeutic strategy in leukemic and lymphoid malignancies, continues to provid ... Show More
1h 30m
Oct 2023
Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)
<p class="" style="white-space:pre-wrap;">This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out ... Show More
35m 55s
Listen to millions of songs and podcasts on Anghami